The stock's rise snapped a four-day losing streak.

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...

Fintel reports that on February 10, 2025, Barclays downgraded their outlook for Illumina (NasdaqGS:ILMN) from Equal-Weight to ...

The placement of Illumina in China's unreliable entity list could have disruptive implications. Read why I remain bullish on ...

Illumina is part of the Health Care sector, which has an average P/E ratio of 26.07 and an average P/B of 3.53 The company ...

Illumina, Inc. ILMN reported better-than-expected results for its fourth quarter on Thursday. The company posted quarterly ...

After China placed Illumina on a government watchlist this week, in response to new tariffs imposed by the Trump ...

TD Cowen downgraded Illumina (ILMN) to Hold from Buy with a $140 price target Maximize Your Portfolio with Data Driven Insights:Leverage the ...

The company forecast annual revenue of $4.28 billion to $4.4 billion for 2025, the midpoint of which is below analysts' ...

Investors are assessing China's instant retaliation to Trump's additional tariffs, amid worries about the risk of a trade war ...

Some calm is returning to Wall Street Tuesday, and U.S. stock indexes are making only modest moves in early trading after ...

Needham analyst Ryan Koontz upgraded Viavi Solutions (NASDAQ:VIAV) from Hold to Buy and a $15 price forecast after the ... Koontz upgraded Viavi Solutions’ stock rating. The analyst noted ...